Open-Label Study to Determine the Feasibility of Ixazomib As Maintenance after Allogeneic Stem Cell Transplant for Multiple Myeloma

Carlos R Bachier; Paul J Shaughnessy; Jeffrey V Matous; Jesus G. Berdeja

doi:10.1182/BLOOD.V130.SUPPL_1.5537.5537

Open-Label Study to Determine the Feasibility of Ixazomib As Maintenance after Allogeneic Stem Cell Transplant for Multiple Myeloma

Carlos R Bachier
, Paul J Shaughnessy
, Jeffrey V Matous
, Jesus G. Berdeja

Sarah Cannon Research Institute
Sarah Cannon Blood Cancer Network, Nashville, TN

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	130
DOIs	https://doi.org/10.1182/BLOOD.V130.SUPPL_1.5537.5537
State	Published - Dec 7 2017
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1182/BLOOD.V130.SUPPL_1.5537.5537License: Unspecified

Cite this

@article{6a0a9ff3f61042e2b619f6b00432f4f3,

title = "Open-Label Study to Determine the Feasibility of Ixazomib As Maintenance after Allogeneic Stem Cell Transplant for Multiple Myeloma",

author = "Bachier, \{Carlos R\} and Shaughnessy, \{Paul J\} and Matous, \{Jeffrey V\} and Berdeja, \{Jesus G.\}",

note = "Carlos R Bachier, Paul J Shaughnessy, Jeffrey V Matous, Jesus G. Berdeja; Open-Label Study to Determine the Feasibility of Ixazomib As Maintenance after Allogeneic Stem Cell Transplant for Multiple Myeloma. 2017; 130 (Supplement 1): 5537. doi: https://doi.org/10.1182/blood.V130.Suppl\_1.5537.5537 Download citation file:",

year = "2017",

month = dec,

day = "7",

doi = "10.1182/BLOOD.V130.SUPPL\_1.5537.5537",

language = "American English",

volume = "130",

journal = "Blood",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Open-Label Study to Determine the Feasibility of Ixazomib As Maintenance after Allogeneic Stem Cell Transplant for Multiple Myeloma

AU - Bachier, Carlos R

AU - Shaughnessy, Paul J

AU - Matous, Jeffrey V

AU - Berdeja, Jesus G.

N1 - Carlos R Bachier, Paul J Shaughnessy, Jeffrey V Matous, Jesus G. Berdeja; Open-Label Study to Determine the Feasibility of Ixazomib As Maintenance after Allogeneic Stem Cell Transplant for Multiple Myeloma. 2017; 130 (Supplement 1): 5537. doi: https://doi.org/10.1182/blood.V130.Suppl_1.5537.5537 Download citation file:

PY - 2017/12/7

Y1 - 2017/12/7

UR - https://ashpublications.org/blood/article/130/Supplement%201/5537/115800/Open-Label-Study-to-Determine-the-Feasibility-of

U2 - 10.1182/BLOOD.V130.SUPPL_1.5537.5537

DO - 10.1182/BLOOD.V130.SUPPL_1.5537.5537

M3 - Article

VL - 130

JO - Blood

JF - Blood

ER -

Open-Label Study to Determine the Feasibility of Ixazomib As Maintenance after Allogeneic Stem Cell Transplant for Multiple Myeloma

Disciplines

Access to Document

Other files and links

Cite this